Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty.

Abstract:

:Hormone replacement therapy has been associated with venous thromboembolism. Controversy exists regarding the appropriate management of hormone replacement in the perioperative setting and in other situations--such as acute illness--predisposing to acute venous thromboembolism. We performed a case-control study to determine whether perioperative hormone replacement is associated with venous thromboembolism following hip and knee arthroplasty. 108 patients with postoperative venous thrombosis were matched by age, date and type of surgery, and surgeon with 210 controls without thrombosis. Perioperative hormone replacement use was no more prevalent in patients with postoperative thrombosis than those without. Eighteen (16.7%) women with post-operative thrombosis had taken perioperative hormone replacement compared to 49 (23.3%) of controls: odds ratio = 0.66; (95% CI 0.35-1.18; p=0.17). After multivariate analysis, the adjusted odds ratios were similar. Variables predicting post-operative thrombosis included: prior venous thromboembolism (OR = 2.3; p = 0.02), rheumatologic disease (OR = 2.2; p = 0.03), and absence of pharmacologic antithrombotic prophylaxis (OR = 13.4; p = 0.005). Cases and controls were otherwise similar. Users of hormone replacement were similar to non-users except that they were less likely to have coronary disease (OR 0.34; p = 0.03) or prior thrombosis (OR = 0.28; p = 0.04), and were younger (median age 67 versus 74 years; p <0.0001). We found no association between perioperative hormone replacement and post-operative thrombosis in patients undergoing major orthopaedic surgery. Routine discontinuation of these medications preoperatively--and possibly in other situations predisposing to thrombosis, such as acute medical illness--may be unnecessary in patients receiving appropriate pharmacologic antithrombotic prophylaxis.

journal_name

Thromb Haemost

authors

Hurbanek JG,Jaffer AK,Morra N,Karafa M,Brotman DJ

doi

10.1160/TH04-03-0165

keywords:

subject

Has Abstract

pub_date

2004-08-01 00:00:00

pages

337-43

issue

2

eissn

0340-6245

issn

2567-689X

pii

04080337

journal_volume

92

pub_type

杂志文章
  • Opposite relationship between circulating soluble CD14 concentration and endothelial function in diabetic and nondiabetic subjects.

    abstract::Recent prospective studies indicate endothelial dysfunction and increased risk for cardiovascular events in patients with serological evidence of multiple infections. Soluble CD14 (sCD 14) plays a key role in the neutralization of lipopolysaccharide (LPS), a well-established bacterial product inducing endothelial dysf...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH04-12-0831

    authors: Fernández-Real JM,López-Bermejo A,Castro A,Broch M,Peñarroja G,Vendrell J,Vázquez G,Ricart W

    更新日期:2005-09-01 00:00:00

  • Detection and neutralisation of heparin by a fluorescent ruthenium compound.

    abstract::Heparin and low-molecular-weight heparin (LMWH) are commonly monitored by determination of activated clotting times or chromogenic assays. Despite their wide use, these assays determine the biological activity and not the concentration of the anticoagulants. They may be inaccurate in some circumstances such as certain...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH09-03-0168

    authors: Szelke H,Harenberg J,Krämer R

    更新日期:2009-11-01 00:00:00

  • Thrombin receptors in vascular smooth muscle cells - function and regulation by vasodilatory prostaglandins.

    abstract::The vast majority of thrombin (>95%) is generated after clotting is completed, suggesting that thrombin formation serves purposes beyond coagulation, such as tissue repair after vessel injury. Two types of vascular thrombin binding sites exist: protease-activated receptors (PARs) and thrombomodulin (TM). Their express...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH09-09-0627

    authors: Schrör K,Bretschneider E,Fischer K,Fischer JW,Pape R,Rauch BH,Rosenkranz AC,Weber AA

    更新日期:2010-05-01 00:00:00

  • Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia.

    abstract::Cysteinyl leukotrienes (i.e. LTC4, LTD4), produced by activated leukocytes or by transcellular metabolism may act at different levels on vascular smooth muscle cells (VSMC) during inflammatory process or atherosclerosis. We studied the effect of LTC4, LTD4, and LTE4 on the in vitro proliferation of rat VSMC, measured ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Porreca E,Di Febbo C,Di Sciullo A,Angelucci D,Nasuti M,Vitullo P,Reale M,Conti P,Cuccurullo F,Poggi A

    更新日期:1996-07-01 00:00:00

  • Pharmacogenetics role in the safety of acenocoumarol therapy.

    abstract::Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and prevention of thrombotic disorders in many countries, despite the recent approval of the new oral anticoagulants (NOACs). Although effectiveness and safety of VKAs are tightly associated to maintaining the patient within the internationa...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH13-11-0941

    authors: Jiménez-Varo E,Cañadas-Garre M,Henriques CI,Pinheiro AM,Gutiérrez-Pimentel MJ,Calleja-Hernández MÁ

    更新日期:2014-09-02 00:00:00

  • Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.

    abstract::Forty-two patients with total occlusion of a coronary vessel were treated with intracoronary fibrinolytic agents. Four therapeutic protocols were compared: group I received streptokinase (SK) as a continuous infusion; group II and III received SK as a bolus at different doses and group IV received lysplasminogen (Pg) ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: de Prost D,Guerot C,Laffay N,Horellou MH,Samama M

    更新日期:1983-12-30 00:00:00

  • The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.

    abstract:STUDY OBJECTIVE:Cytokines increase endothelial tissue factor (TF) and tissue plasminogen activator inhibitor type-1 (PAI-1) expression in vitro. Tissue factor interacts with factor VII to facilitate thrombosis and PAI-1 inhibits fibrinolysis by endogenous plasminogen activators. Because cytokine release is increased in...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Green J,Doughty L,Kaplan SS,Sasser H,Carcillo JA

    更新日期:2002-02-01 00:00:00

  • Long Noncoding RNAs of the Arterial Wall as Therapeutic Agents and Targets in Atherosclerosis.

    abstract::Long noncoding ribonucleic acids (lncRNAs) have been defined as transcripts which are > 200 ribonucleotides in size and are not translated into protein. Recent work has shown that many lncRNAs do have specific molecular functions and biological effects, and are involved in a growing number of diseases, including ather...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1692680

    authors: Holdt LM,Kohlmaier A,Teupser D

    更新日期:2019-08-01 00:00:00

  • Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka.

    abstract::The acidic mucopolysaccharide extracted from sea cucumber (Stichopus japonicus Selenka) (SJAMP) has been shown to cause platelets to aggregate. Using citrated platelet-rich plasma (PRP), washed platelets and formaldehyde-fixed platelets from humans, we investigated the effects of platelet inhibitors and various plasma...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Li JZ,Lian EC

    更新日期:1988-06-16 00:00:00

  • Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.

    abstract::The influence of changes in liver blood flow on the clearance of rt-PA was studied both in healthy subjects and in a perfused rat liver model. Liver blood flow in healthy subjects was documented indirectly by the clearance of indocyanine green (ICG). Exercise reduced liver blood flow on average by 57% with a 95% confi...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: de Boer A,Kluft C,Kroon JM,Kasper FJ,Schoemaker HC,Pruis J,Breimer DD,Soons PA,Emeis JJ,Cohen AF

    更新日期:1992-01-23 00:00:00

  • Erratum to Parasrampuria et al. "Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis" (Thromb Haemost 2015; 113: 719-727).

    abstract::[This corrects the article DOI: 10.1160/TH14-06-0547.]. ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,已发布勘误

    doi:10.1160/TH17040001

    authors:

    更新日期:2017-04-03 00:00:00

  • Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.

    abstract::Gender and the 4G/5G polymorphism in the plasminogen activator inhibitor 1 (PAI-1) gene are believed to play a role in the regulation of plasma PAI-1 activity. Adipose tissue has been found to be an important source of PAI-1. The possible influence of gender and the 4G/5G polymorphism in the PAI-1 gene on PAI-1 secret...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: van Harmelen V,Wahrenberg H,Eriksson P,Arner P

    更新日期:2000-02-01 00:00:00

  • Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis.

    abstract::Noninvasive diagnosis of deep vein thrombosis (DVT) is based on ultrasound examination of the leg veins, usually restricted to only compression of the proximal veins (CUS). Patients with negative CUS findings require a second examination or a combination with other tests, which impairs clinical efficiency. In this pro...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Schellong SM,Schwarz T,Halbritter K,Beyer J,Siegert G,Oettler W,Schmidt B,Schroeder HE

    更新日期:2003-02-01 00:00:00

  • Recombinant factor VIIa does not induce hypercoagulability in vitro.

    abstract::Recombinant factor VIIa (rVIIa) has been reported to be clinically effective and safe in haemophilic patients with inhibitor antibodies. Compared to activated prothrombin complex concentrates the risk of thrombotic complications seems to be very low after rVIIa administration. Determination of free thrombin generation...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Gallistl S,Cvirn G,Muntean W

    更新日期:1999-02-01 00:00:00

  • The burden of inhibitors in haemophilia patients.

    abstract::The burden of disease in haemophilia patients has wide ranging implications for the family and to society. There is evidence that having a current inhibitor increases the risk of morbidity and mortality. Morbidity is increased by the inability to treat adequately and its consequent disabilities, which then equates to ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH16-01-0049

    authors: Walsh CE,Jiménez-Yuste V,Auerswald G,Grancha S

    更新日期:2016-08-31 00:00:00

  • Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.

    abstract::Platelet aggregation and adenine nucleotides in platelets have been studied in thirteen patients with myeloproliferative disorders. ADP induced aggregation was abnormal in two patients, but collagen induced aggregation was impaired in 11 patients. The concentrations of ATP and ADP in resting platelets in the patients ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Nishimura J,Okamoto S,Ibayashi H

    更新日期:1979-06-30 00:00:00

  • Characterization of the anticoagulant activities from a Brazilian arrow poison.

    abstract::A recent report indicated that an arrow poison used by the native Indians of Rondonia, Brazil, to kill small animals was associated with profuse bleeding. The arrow poison was prepared from the bark of a tree, known locally as Tike-Uba. We have obtained bark and sap specimens from this tree and have characterized a po...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Jacobs JW,Petroski C,Friedman PA,Simpson E

    更新日期:1990-02-19 00:00:00

  • The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.

    abstract::Aspirin prevents thrombotic events by inhibiting platelet cyclooxygenase-1 (COX-1), thus reducing thromboxane A2 formation and platelet aggregation. The C50T polymorphism of COX-1 is associated with an impaired inhibition of both thromboxane production and in-vitro platelet aggregation by aspirin. We studied whether t...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章

    doi:10.1160/TH08-03-0172

    authors: Clappers N,van Oijen MG,Sundaresan S,Brouwer MA,Te Morsche RH,Keuper W,Peters WH,Drenth JP,Verheugt FW

    更新日期:2008-07-01 00:00:00

  • Magnetic resonance imaging of tumor vasculature.

    abstract::Angiogenic activity and formation of a vascular network facilitate tumor perfusion and play a critical role in tumor growth and metastasis. Tumor vasculature may be visualized by means of parametric imaging of specific morphological and physiological characteristics that collectively describe its properties. In this r...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Degani H,Chetrit-Dadiani M,Bogin L,Furman-Haran E

    更新日期:2003-01-01 00:00:00

  • Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.

    abstract::Global coagulation assays display variable effects at different concentrations of rivaroxaban. The aim of this study is to quantify the ex vivo effects of low-dose rivaroxaban on thrombophilia screening assays and coagulation factor activities based on the administration time, and to show how to mask possible inter...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH12-04-0228

    authors: Mani H,Hesse C,Stratmann G,Lindhoff-Last E

    更新日期:2013-01-01 00:00:00

  • Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood.

    abstract::Thrombus formation at an artificial surface in contact with blood is a complex process that encompasses accretion of platelets from flowing blood and fibrin deposition. Platelet adhesion and fibrin formation are intimately intertwined reactions that are triggered by different sets of surface adsorbed plasma proteins. ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Keuren JF,Wielders SJ,Willems GM,Morra M,Lindhout T

    更新日期:2002-04-01 00:00:00

  • Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.

    abstract::We compared the anticoagulant, antithrombotic and bleeding effects of highly sulfated dermatan sulfates from invertebrates and their mammalian counterpart. An invertebrate dermatan sulfate containing 2-O-sulfated alpha-L-iduronic acid and 4-O-sulfated N-acetyl-beta-D-galactosamine residues is a potent anticoagulant du...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Vicente CP,Zancan P,Peixoto LL,Alves-Sá R,Araújo FS,Mourão PA,Pavão MS

    更新日期:2001-11-01 00:00:00

  • The factor VIII bypassing activity of prothrombin complex concentrates: the roles of factor VIIa and of endothelial cell tissue factor.

    abstract::An experimental model incorporating cultured endothelial cells (EC) was used to study the "factor VIII bypassing" activity of prothrombin complex concentrates (PCC), a property exploited in the treatment of hemophiliacs with alloantibodies to factor VIII. Two PCC preparations were ineffective as stimuli of tissue fact...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Teitel JM

    更新日期:1991-11-01 00:00:00

  • Ciglitazone inhibits plasmin-induced proinflammatory monocyte activation via modulation of p38 MAP kinase activity.

    abstract::Plasmin triggers chemotaxis and NF-kappa B- and AP-1-mediated proinflammatory gene expression in human peripheral monocytes (PM). Compared with macrophages and dendritic cells, PM express mainly the peroxisome proliferator-activated receptor (PPAR) gamma and traces of PPAR alpha as detected by semiquantitative RT-PCR ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Syrovets T,Schüle A,Jendrach M,Büchele B,Simmet T

    更新日期:2002-08-01 00:00:00

  • Sustained impact of electronic alerts on rate of prophylaxis against venous thromboembolism.

    abstract::Advanced electronic alerts (eAlerts) and computerised physician order entry (CPOE) increase adequate thromboprophylaxis orders among hospitalised medical patients. It remains unclear whether eAlerts maintain their efficacy over time, after withdrawal of continuing medical education (CME) on eAlerts and on thromboproph...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH11-04-0220

    authors: Beeler PE,Kucher N,Blaser J

    更新日期:2011-10-01 00:00:00

  • Non-occlusive bleeding times may improve the value of Ivy bleeding times.

    abstract::The present studies measured bleeding times, without venous occlusion, in a series of patients, whose bleeding times (+ venostasis) consistently exceeded 20 min. During these tests, the amount of blood loss (expressed as mg/min) was also quantitated. To allow comparison, normal controls were studied before and followi...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Zeigler ZR

    更新日期:1990-06-28 00:00:00

  • Haemophilia B: impact on patients and economic burden of disease.

    abstract::Worldwide, haemophilia is the most common hereditary bleeding disorder. The incidence of haemophilia B, however, is considerably less than haemophilia A and consequently appears to have received less attention in the research literature. This article aims to summarise the available evidence documenting the patient and...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH11-03-0193

    authors: Gater A,Thomson TA,Strandberg-Larsen M

    更新日期:2011-09-01 00:00:00

  • Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys.

    abstract::The turnover of recombinant pro-urokinase (Rec-pro-UK), recombinant urokinase (Rec-UK) and natural urinary urokinase (Nat-UK) was studied in rabbits and in squirrel monkeys (Saimiri sciureus). Following intravenous injection, urokinase activity disappeared rapidly from the blood. The initial disappearance rate could b...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Collen D,De Cock F,Lijnen HR

    更新日期:1984-08-31 00:00:00

  • Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort.

    abstract::Severe postpartum haemorrhages (PPH) are responsible for maternal morbidity/mortality. Their complex management sometimes requires haemostatic supplementation, and therapeutic trials on fibrinogen or activated factor VII, which may add to the thrombotic risk, are currently being considered. Furthermore, there is a ris...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Chauleur C,Cochery-Nouvellon E,Mercier E,Aya G,Marès P,Mismetti P,Lissalde-Lavigne G,Gris JC

    更新日期:2008-11-01 00:00:00

  • DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model.

    abstract::DX-9065a is an antithrombin III (AT III)-independent and selective inhibitor of activated blood coagulation factor X (FXa). We evaluated the effects of DX-9065a and warfarin on bleeding time and blood loss in rat tail transection model and on blood loss in hydrochloride (HCl)-induced rat gastrointestinal haemorrhage m...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Tanabe K,Morishima Y,Shibutani T,Terada Y,Hara T,Shinohara Y,Aoyagi K,Kunitada S,Kondo T

    更新日期:1999-05-01 00:00:00